2024 On-Demand ADA Education Recognition Program Symposiums | American Diabetes Association

We are excited to announce that the ERP DSMES Symposium and the Medicare Reimbursement symposium are now available on-demand until December 31, 2024. Both symposiums are accredited health care provider continuing education programs that will award CEU’s to physicians, physician assistants, nurses, dietitians, pharmacists, and certified diabetes care and education specialists. This program will guide attendees through establishing and maintaining a DSMES service that adheres to the 2022 National Sta

Read the full article here

Source: professional.diabetes.org

Categories: Endocrinology, General Medicine News

Tweets with this article

ADA DiabetesPro

Elevate your expertise in diabetes management and Medicare reimbursement while earning CEUs with our latest online courses! Discover essential insights and strategies to stay ahead in the field. Register now: https://t.co/aqF3ssI3vH https://t.co/SfNtLUwCHM

Transcriptomic profiling and machine learning reveal novel RNA signatures for enhanced molecular characterization of Hashimoto’s thyroiditis

Scientific Reports – Transcriptomic profiling and machine learning reveal novel RNA signatures for enhanced molecular characterization of Hashimoto’s thyroiditis

Johnson Thomas, MD, FACE January 4, 2025

Welcome! You are invited to join a webinar: Diabetes 101: The Science of Diabetes and the Law. After registering, you will receive a confirmation email about joining the webinar.

Join the American Diabetes Association and learn about the science of diabetes as it relates to legal issues. The presentation will provide an overview of…

ADA DiabetesPro January 4, 2025

Type 1 Diabetes | ADA

Get all the information on type 1 diabetes you need to better help the people you treat.

ADA DiabetesPro January 3, 2025

Welcome! You are invited to join a meeting: Using Automated Insulin Delivery Devices in Diabetes Management. After registering, you will receive a confirmation email about joining the meeting.

This workshop–designed for primary care professionals, endocrinologists and other members of the diabetes care team–will offer participants an opportunity to learn from health care professionals…

ADA DiabetesPro January 3, 2025

Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial

All tested survodutide doses were tolerated, and dose-dependently reduced bodyweight.

The Lancet Diabetes & Endocrinology January 3, 2025

Abstracts | American Diabetes Association

Submit your abstract for consideration for the 84 th Scientific Sessions. The Scientific Sessions Meeting Planning Committee encourages submissions that are innovative, challenge current treatment…

ADA DiabetesPro January 3, 2025

Related Articles